Avedro, Inc. develops ophthalmic medical devices and pharmaceutical products. The firm's products include KXL System, Mosaic system, IROC system and Riboflavin family. Its procedure includes Lasic Xtra, accelerated cross-linking and photorefractive intrastromal cross-linking. The company was founded by David F. Muller and B. Stuart Trembly on November 6, 2002 and is headquartered in Waltham, MA.
![Avedro logo](/files/LOGO/1343304-AVDR.png)
Company profile
Ticker
AVDR
Exchange
Website
CEO
Reza Zadno
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Latest filings (excl ownership)
15-12B
Securities registration termination
2 Dec 19
25-NSE
Exchange delisting
21 Nov 19
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Nov 19
8-K
Completion of Acquisition or Disposition of Assets
21 Nov 19
8-K
Departure of Directors or Certain Officers
18 Nov 19
425
Business combination disclosure
18 Nov 19
425
Business combination disclosure
14 Nov 19
8-K
Other Events
8 Nov 19
425
Business combination disclosure
8 Nov 19
425
Business combination disclosure
7 Nov 19
Latest ownership filings
Institutional ownership, Q4 2019
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 60 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Proequities | 0.00 | $0.00 |